Thierry Poynard
- Hepatology top 0.01%
- Hepatitis C virus research 218
- Liver Disease and Transplantation 76
- Liver Diseases and Immunity 25
- Hepatocellular Carcinoma Treatment and Prognosis 23
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment 272
- Hepatitis B Virus Studies 135
- Pathology and Forensic Medicine top 0.2%
- Alcohol Consumption and Health Effects 36
- Gastroenterology top 0.5%
-
- Systemic Lupus Erythematosus Research 23
- Co-authors
- Pierre BédossaVlad RatziuP OpolonFrédéric CharlotteYves BenhamouJohn G. McHutchisonJanice K. AlbrechtChing‐Lung Lai
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Thierry Poynard
426 papers receiving 42.2k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Hepatology 33.9k
- Epidemiology 36.1k
- Endocrinology, Diabetes and Metabolism 3.3k
- Pathology and Forensic Medicine 3.1k
- Gastroenterology 868
Countries citing papers authored by Thierry Poynard
This map shows the geographic impact of Thierry Poynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Poynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Poynard more than expected).
Fields of papers citing papers by Thierry Poynard
This network shows the impact of papers produced by Thierry Poynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Poynard. The network helps show where Thierry Poynard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thierry Poynard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 19 | |
| 2 | 2008 | 34 | |
| 3 | 2007 | 33 | |
| 4 | 2007 | 81 | |
| 5 | 2007 | 4 | |
| 6 | 2005 | 304 | |
| 7 | Phase Iib Extended-Treatment Trial of Telbivudine (LdT) Vs Lamivudine Vs Combination Treatment in Hepatitis B Patients: Two-Year Results | 2005 | 12 |
| 8 | Quelles sont les indications du traitement dans l'hépatite C aiguë ? | 2002 | 2 |
| 9 | 2002 | 21 | |
| 10 | 2002 | 344 | |
| 11 | 1999 | 207 | |
| 12 | 1999 | 164 | |
| 13 | 1999 | 80 | |
| 14 | 1998 | 136 | |
| 15 | 1992 | 29 | |
| 16 | [Is fluindione hepatotoxic?]. | 1990 | 4 |
| 17 | 1985 | 40 | |
| 18 | Metformin reduces post prandial insulin needs in type 1 diabetics assessment by the artificial pancreas | 1981 | 7 |
| 19 | Recherche d'une infection à cytomégalovirus au cours des colites pseudo-membraneuses. 6 observations. | 1981 | 2 |
| 20 | [Intestinal functional disorders: review of the literature]. | 1977 | 2 |
About Thierry Poynard
Thierry Poynard is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 427 papers that have together received 43.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (272 papers), Hepatitis C virus research (218 papers), Hepatitis B Virus Studies (135 papers), Liver Disease and Transplantation (76 papers), Alcohol Consumption and Health Effects (36 papers), Liver Diseases and Immunity (25 papers), Systemic Lupus Erythematosus Research (23 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). The work is most often cited by research in Hepatology (33.9k citations), Epidemiology (36.1k citations) and Endocrinology, Diabetes and Metabolism (3.3k citations). Thierry Poynard has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Pierre Bédossa, Vlad Ratziu, P Opolon, Frédéric Charlotte, Yves Benhamou, John G. McHutchison, Janice K. Albrecht, Ching‐Lung Lai, Françoise Imbert‐Bismut and Man‐Fung Yuen. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Journal of Viral Hepatitis and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.